Comments on: May’s top stories: Thermo Fisher Scientific buys Patheon for $7.2bn, AstraZeneca to sell rights for Seloken /features/featuremays-top-stories-thermo-fisher-scientific-agrees-to-buy-patheon-for-72bn-astrazeneca-signs-deal-to-sell-commercial-rights-for-seloken-in-europe-5834239/ The leading site for news and procurement in the pharmaceutical industry Mon, 05 Jun 2017 17:30:00 +0000 hourly 1 https://wordpress.org/?v=6.7.2